Trial Profile
Irbesartan and Olmesartan in Japanese Patients With Hypertension
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Aug 2012
Price :
$35
*
At a glance
- Drugs Irbesartan (Primary) ; Olmesartan medoxomil (Primary)
- Indications Essential hypertension
- Focus Therapeutic Use
- Acronyms EARTH
- 16 Aug 2012 New trial record
- 01 Aug 2012 Results published in the Clinical and Experimental Hypertension (CEH).